Clinical Trials in Salt Lake City

Showing 1681-1700 of 14,325 trials

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

NCT03375047

This Phase 1/2, first-in-human study evaluated the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with cystic fibrosis (CF).

Cystic Fibrosis

Sanofi42 participantsStarted May 2018

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +13 more locations

Active Not RecruitingPhase 3< 1 mile

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

NCT06274801

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

Pulmonary Arterial Hypertension

GB002, Inc.316 participantsStarted Sep 2024

Fresno, California, United States • Los Angeles, California, United States • Sacramento, California, United States +112 more locations

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Find Trials by Condition in Salt Lake City

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

A Prospective Sub-Study of the Global Hypophosphatasia Registry

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Galleri® in the Medicare Population.

His-Bundle Corrective Pacing in Heart Failure

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

FX Shoulder Prospective Clinical Study

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Study of ATX-01 in Participants With DM1

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Intermuscular Coherence as a Biomarker for ALS

LURN: Urinary Urgency Phenotyping Protocol